MARKET

AZN

AZN

AstraZeneca
NYSE
204.76
+11.36
+5.87%
After Hours: 204.73 -0.03 -0.01% 17:18 02/11 EST
OPEN
200.08
PREV CLOSE
193.40
HIGH
204.92
LOW
199.19
VOLUME
3.46M
TURNOVER
--
52 WEEK HIGH
204.92
52 WEEK LOW
123.36
MARKET CAP
317.57B
P/E (TTM)
31.28
1D
5D
1M
3M
1Y
5Y
1D
Former AstraZeneca regional head officially charged in China
Seeking Alpha · 6h ago
Midday Fly By: January payrolls jump, Ford reports mixed Q4
TipRanks · 7h ago
AstraZeneca awards $3.4 million to U.S. nonprofits to expand healthcare access
Seeking Alpha · 10h ago
AstraZeneca Earnings Call Highlights Growth And Pipeline
TipRanks · 1d ago
AstraZeneca: Q4 Earnings Analysis - Ticks The Boxes, Upgrading To Buy
Seeking Alpha · 1d ago
AstraZeneca PLC declares $2.17 dividend
Seeking Alpha · 1d ago
AVDE: Diversified And Effective Active ETF At A Low Cost
Seeking Alpha · 1d ago
Market Voices: Paramount-WBD bid, Holtec IPO, AstraZeneca
Seeking Alpha · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca plc stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.